PE Firms To Pay $4.25B For Baxter's BioPharma Solutions Biz
Sullivan & Cromwell-led Baxter International Inc. said Monday it has agreed to sell its BioPharma Solutions business to private equity firms Advent International and Warburg Pincus for $4.25 billion....To view the full article, register now.
Already a subscriber? Click here to view full article